Romania

 

HBI 2023 Panel: The Homecare Technology Revolution

When election seasons roll around, reforming social care is often allegedly at the top of party agendas, yet care systems across Europe remain chronically underfunded and under stress. In an HBI 2023 panel entitled ‘The homecare technology revolution’, three business founders shared how technology and their business models are disrupting the home care sector.

HBI 2023: The outpatient differential

For years there has been a trend towards using outpatient services wherever possible - to improve patient outcomes, to better use an increasingly scarce workforce, and to increase cost efficiency. On the “Outpatient differential” panel at HBI 2023, how this push looks across the world was a key topic for discussion.

Mubadala-backed M42 buying Diaverum “for $2bn+”

Swedish multinational dialysis firm Diaverum is being bought by M42, a joint venture between Abu Dhabi sovereign wealth fund Mubadala Investment Co and AI firm G42, for a reported $2bn-$2.5bn. Diaverum’s CEO tells HBI the deal offers further opportunities to develop its digital strategies, and international expansion. 

Digital health booming in CEE

Digital health is booming in Central and Eastern Europe (CEE), boosted by several countries in the region introducing major policy initiatives to integrate telehealth solutions and digitise their health systems. CEE-based multinational law firm Kinstellar spells this out in its latest ‘Current eHealth trends in CEE and Turkey’ report.

Diaverum deal: An analysis

Last week the news broke that Abu Dhabi sovereign wealth fund Mubadala Investment Co might be set to buy Swedish multinational dialysis firm Diaverum for a reported $2.5bn. HBI speaks to an operator source who thinks this would be a good price for the seller - and hears why some investors are switched off by dialysis.

Inflow of nurses to top five European markets

This week, HBI looks at the annual inflow of nurses from abroad to the big five Western European markets - the United Kingdom, Germany, France, Italy, and Spain - using public data from OECD. Those looking for an outlier need look no further than the UK.

Cinven looks to take Synlab private as Covid boost falters

Frankfurt-listed Synlab could be about to be taken private following a non-binding full takeover offer earlier this week. With its full year results released yesterday and facing questions about its plans, HBI asks market experts what they think of the move.

Find Us